Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Benefit-Risk Assessment Based on Number Needed to Treat and Number Needed to Harm: Atogepant vs Calcitonin Gene–Related Peptide Monoclonal Antibodies

Author:Sacco, Simona   Lalla, Anjana   Halker Singh, Rashmi   Holle-Lee, Dagney   Pozo-Rosich, Patricia   Nagy, Krisztian   Kelton, Kari   Piron, Cristiano   Gandhi, Pranav   Ailani, Jessica   

Session Name:P5: Headache: Advances in CGRP Inhibition 1  

Topic:Headache  

Program Number:P5.007  

Author Institution:University of L'Aquila, L'Aquila, Italy  AbbVie, Irvine, CA  Mayo Clinic, Scottsdale, AZ  Department of Neurology, West German Headache  Vertigo Center Essen, University of Essen, Essen, Germany  Vall d’Hebron University Hospital  Vall d’Hebron Institute of Research, Universitat Autònoma de Barcelona, Barcelona, Spain  AbbVie, Budapest, Hungary  Medical Decision Modeling Inc., Indianapolis, IN  AbbVie, Madison, NJ  Medstar Georgetown Neurology, McLean, VA  

Renal Manifestations in CASPR2 Antibody-associated Diseases

Author:Kandikonda, Rajender   Kannoth, Sudheeran   Nambiar, Vivek   Gopinath, Sibi   Saraf, Udit   Unnikrishnan, Gopikrishnan   Anandakuttan, Anand Kumar   Mathai, Annamma   Leelamaniamma, Jyothi   

Session Name:P5: Autoimmune Neurology: Autoimmune Encephalitis and Other Autoantibody Associated Syndromes  

Topic:Autoimmune Neurology  

Program Number:P5.007  

Author Institution:Amrita Institute, ALUVA, India  Amrita Institute, Kochi, India  Amrita Institute of Medical Sciences, Kochi, India  Amrita Institute, aims ponekarra kochi, India  

Place of Death Surrounding Motor Neuron Disease Mortality in the United States Before and During the COVID-19 Pandemic, 2018-2021

Author:Han, Moon   Raymond, Jaime   Mehta, Paul   Larson, Theodore   Horton, D Kevin   

Session Name:P5: Palliative Care  

Topic:Palliative Care  

Program Number:P5.007  

Author Institution:Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry, Marietta, GA  

Understanding Post-traumatic Epilepsy in Pediatric Patients with Abusive Head Trauma

Author:Messer, Ricka   Madison, Casey   Graber, Sarah   Connery, Amy   

Session Name:P5: Child Neurology and Developmental Neurology: Pediatric Critical Care  

Topic:Child Neurology and Developmental Neurology  

Program Number:P5.007  

Author Institution:Children's Hospital Colorado, Aurora, CO  

Clinician Education Initiatives for General Neurologists on ALS: Why It Is Needed and ThinkALS, a Possible Solution

Author:Babu, Suma   Yersak, Jill   Krauss, Ramona   Oskarsson, Bjorn   Heiman-Patterson, Terry   Lomen-Hoerth, Catherine   Waldo, Dan   Selig, Wendy   Halpern Paul, Ilisa   Dave, Kuldip   Thakur, Neil   

Session Name:P5: Neuromuscular and Clinical Neurophysiology (EMG): Amyotrophic Lateral Sclerosis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P5.008  

Author Institution:Massachusetts General Hospital, Brigham, Harvard, Boston, MA  Amylyx, Washington, DC  Actuarial Research Corporation, Anandale, VA  Mayo Clinic, Jacksonville, FL  Temple University Lewis Katz School of Medicine, Philadelphia, PA  UCSF, San Francisco, CA  WSCollaborative LLC, mclean, VA  Venable LLP , Washington, DC  ALS Association, arlington, VA